|Philanthropist T. Denny Sanford is donating $100 million for stem cell research to the University of California at San Diego.(Photo: Lara Neel, (Sioux Falls, S.D.) Argus Leader)|
SIOUX FALLS, S.D. A philanthropist who made his money as a credit card provider is giving $100 million to human stem-cell research.
The money will go to the University of California at San Diego during the next five years as researchers reach certain milestones, said T. Denny Sanford, who founded First Premier Bank here and offers low-limit Mastercards and Visas to customers with poor credit through Premier Bankcard. United National Corp., where Sanford is now chief executive, owns both companies.
"This, in my opinion, is the medicine of the future," he said. "The potential of stem cells is just unbelievable."
The money will support the hiring of 20 or more scientists and efforts to recruit patients for drug trials along with new construction at the San Diego complex.
The donation pushes Sanford past the $1 billion mark for total gifts to health care and research, he said.
Sanford, 77, has homes in South Dakota, Arizona and California. On Oct. 19, he suffered a pulmonary embolism a blood clot in the lungs while on a hunting trip with friends near Gregory, S.D., about 140 miles west of here.
He said he was saved because of a middle-of-the-night medical flight to Sanford University of South Dakota Medical Center here, helicopter and plane flights made possible in part because of donations he has made to what is now Sanford Health system.
"I was within minutes or hours of death," he said. His physician here, Dr. Eric Larson, said Sanford is doing fantastic, playing golf regularly and exercising on an elliptical machine, less than a month after getting clot-busting medications to treat the condition.
Most of Sanford's donations, about $700 million, have gone to the Sanford Health. He has pledged to give all his money away. He said he still has close to $1 billion.
The $100 million he is committing to UC San Diego is the lead resource in a project that officials say will cost a total of $275 million.
What now is called the Sanford Consortium for Regenerative Medicine includes scientists from five institutions UC San Diego, Sanford-Burnham, Scripps, the Salk Institute for Biological Studies and the LaJolla Institute for Allergy and Immunology.
"Overall, the effort is to bring stem cell research into human clinical trials," said Debra Kain, director of health sciences research communications at UC San Diego.
In Sioux Falls, Sanford made a $400 million donation to the nonprofit medical center in 2007 and established four priorities, one of which was curing a major disease that officials later pegged as Type 1 diabetes. Another of his donations here, $100 million in 2011, is for research and treatment for breast cancer. His mother, Edith, died of the disease when he was 4 years old.
This gift is different because he has no personal or family connection to the neurological diseases he hopes that stem cell research can address.
Research so far has been instructive on the use of mice and monkeys, so it's time now to extend the effort to humans, he said.
"We are excited about some major potential cures, particularly with neurological diseases like Lou Gehrig's disease, or spinal cord injuries," Sanford said. Lou Gehrig's disease, also called amyotrophic lateral sclerosis, affects nerve cells in the brain and spinal cord that control muscle movement. It has no cure.
Sanford is excited that the work could lead several directions.
"It could be spinal cord injuries, Alzheimer's, Parkinson's, eventually heart and cancer and diabetes," he said.
This site contains copyrighted material the use of which has not always
been specifically authorized by the copyright owner. We are making such
material available in our efforts to advance understanding of
biotechnology and public policy issues. We believe this constitutes a
'fair use' of any such copyrighted material as provided for in section
107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section
107, the material on this site is distributed without profit to those
who have expressed a prior interest in receiving the included
information for research and educational purposes. For more information
go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use
copyrighted material from this site for purposes of your own that go
beyond 'fair use', you must obtain permission from the copyright owner.